Late-Window Tenecteplase for Stroke Works When Thrombectomy's Out of the Question
TRACE-III trial finds benefit for lytic given up to 24 hours after stroke onset
Source: medpagetoday.com
Yongjun Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Yongjun Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Yongjun Wang Today - Breaking & Trending Today
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science
The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.
Source: dicardiology.com
No Benefit of Colchicine After Stroke, TIA: CHANCE-3
The anti-inflammatory agent, started within 24 hours of acute ischemic stroke or TIA, did not reduce subsequent stroke or other vascular events at 90 days in the CHANCE-3 trial.
Source: medscape.com
Study highlights urgent need to protect world
CABI joined an international team of researchers from 57 institutions around the world to share its expertise in a ground-breaking study which highlights the urgent need to protect the world’s forests from non-native pests amid climate change.
Source: eurekalert.org
ISC23 Late-breaker: A New Strategy to Improve Stroke Thrombolysis
LACI-2 shows reduction in cognitive decline after lacunar stroke
Source: dicardiology.com